- Motley Fool
Why Cassava Sciences Stock Is Sinking Today
The biotech stock is feeling the heat from an indictment of a former consultant.
- Barrons.com
Cassava Sciences Shares Plunge on Indictment Against Former Advisor
A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.
- InvestorPlace
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
In 2024, the iShares Biotechnology ETF (NASDAQ:IBB) is up just over 1.5%. If you’re looking for steady, dividend-paying stocks, you can find a number of biotech stocks to buy from the holdings in this fund. However, if you’re looking for the chance to turn a modest investment into, perhaps, generational wealth, the list becomes narrower and carries a lot more risk. But it’s exactly that risk/reward relationship that makes it an attractive sector for speculative investors. Investing in biotech st
